Preliminary Safety and Potential Effect of 6B11-OCIK Adoptive Cell Therapy Against Platinum-Resistant Recurrent or Refractory Ovarian Cancer

by Hongyan Cheng, Hongyan Cheng, Ruiqiong Ma, Ruiqiong Ma, Shang Wang, Shang Wang, Yu Wang, Yingchun Li, Zhijian Tang, Sha Dou, Yuanfen Wang, Honglan Zhu, Xue Ye, Xue Ye, Tianyu Zhang, Yonghua Zhang, Shufen Li, Yonghong Zhao, Yi Li, Heng Cui, Heng Cui, Xiaohong Chang, Xiaohong Chang
Published 2021-08-01